Tempest Therapeutics

TPST

Börsenwert 10,5 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Fidelity Investments Boston, Massachusetts	37,8 Mio. $	+633.237 $	+35	+2 %
2	2 Janus Henderson Investors US Denver, Colorado	27,7 Mio. $	+54.277 $	+3	+0,2 %
3	3 Jennison Associates New York	21,2 Mio. $	-759.885 $	-42	-4 %
4	4 Orbis Allan Gray Hamilton, Bermuda	18,9 Mio. $	–	–	–
5	5 Adage Capital Partners Boston, Massachusetts	12,5 Mio. $	-162.832 $	-9	-1 %
6	6 ArrowMark Colorado Holdings Denver, Colorado	12,1 Mio. $	-289.480 $	-16	-3 %
7	7 BlackRock Fund Advisors San Francisco, California	9,7 Mio. $	+578.960 $	+32	+7 %
8	8 Vanguard Group Malvern, Pennsylvania	8,68 Mio. $	+470.405 $	+26	+7 %
9	9 Portolan Capital Management Boston, Massachusetts	6,18 Mio. $	+2,86 Mio. $	+158	+115 %
10	10 BlackRock Institutional Trust San Francisco, California	4,92 Mio. $	+325.665 $	+18	+8 %
11	11 CQS Cayman Camana Bay, Grand Cayman, Cayman Islands	4,9 Mio. $	–	–	–
12	12 Franklin Resources San Mateo, California	4,55 Mio. $	–	–	–
13	13 Northern Trust Chicago, Illinois	3,76 Mio. $	+1,79 Mio. $	+99	+122 %
14	14 State Street Boston, Massachusetts	3,1 Mio. $	+72.370 $	+4	+3 %
15	15 GMT Capital Atlanta, Georgia	3,08 Mio. $	-108.555 $	-6	-4 %
16	TS 16 Third Security Radford, Virginia	2,67 Mio. $	–	–	–
17	17 Asset Management One Tokyo, Japan	2,22 Mio. $	-199.017 $	-11	-9 %
18	BCM 18 BBT Capital Management Fort Worth, Texas	1,82 Mio. $	–	–	–
19	19 Fuller & Thaler Asset Management San Mateo, California	1,5 Mio. $	-36.185 $	-2	-3 %
20	20 Geode Capital Management Boston, Massachusetts	1,47 Mio. $	+36.185 $	+2	+3 %
21	21 Deutsche Bank Frankfurt Am Main Ge, Germany	1,46 Mio. $	+1,18 Mio. $	+65	+1.300 %
22	22 D.E. Shaw & Co New York	1,21 Mio. $	+777.977 $	+43	+287 %
23	23 Bank of New York Mellon New York	1,03 Mio. $	-72.370 $	-4	-8 %
24	24 BlackRock Investment Management Wilmington, Delaware	943.000 $	+18.092 $	+1	+2 %
25	25 Howland Capital Management Boston, Massachusetts	842.000 $	–	–	–

Tempest Therapeutics TPST Börsenwert 10,5 Mio. $

Tempest Therapeutics

TPST

Börsenwert 10,5 Mio. $